-
RenovoRx to Participate in March 2022 Investor Conferences
-
Roth Capital Starts RenovoRx Inc. (RNXT) at Buy, PT $16
-
RenovoRx (RNXT) IPO Opens Modestly Lower
-
RenovoRx, Inc. (RNXT) Files for up to $36.6M IPO

